Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

NCT02988401 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02988401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02988401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
Lead sponsor
Johns Hopkins University
Phase
Phase 1/2
Overall status
Completed
Start date
December 1, 2017
Completion date
December 17, 2021
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, primary progressive, multiple sclerosis, relapsing-remitting, multiple sclerosis, secondary progressive